Sepranolone: A New Treatment for PMDD?
In this phase II study, sepranolone 10 mg administered subcutaneously during the late luteal phase reduced PMDD symptoms more than placebo.
Neurodevelopmental Disorders in Children Exposed to Antipsychotic Medications During Pregnancy
Prenatal exposure to antipsychotic medications was not associated with increased risk of neurodevelopmental disorders in offspring.
Weekly Roundup for APRIL 1, 2022: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Can Intravenous Ketamine Reduce Risk for Postpartum Depression?
Intravenous ketamine at delivery reduced risk for postpartum depression; however, only in women at high risk for PPD.
Essential Reads: What is the Best Screening Tool for Depression During Pregnancy?
Many women experience depression during pregnancy. What is the best way to identify these women?
Knowns and Unknowns About SSRI Use During Pregnancy in 2022
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on clinical issues regarding prescribing antidepressants during pregnancy with Ob.Gyn News on March 23, 2022. The last 15-20 years have brought enormous attention to the relevant clinical issues regarding prescribing antidepressants during pregnancy. Concern about the effects of fetal exposure to selective serotonin reuptake inhibitors (SSRIs) is appropriate given the [...]